Added something new to the portfolio today $CTLT and
This is not a solicitation to buy, nor is it investment advice!
WKN US1488061029
Company Name: Catalent Inc
https://investor.catalent.com/financial-news/default.aspx
Founded in 2007; went public in 2014
Country: USA
Employees: 19,000
Investment type: medium-term to long-term
Industry: Healthcare
Dividend: None
Current P/E ratio: 27.45
Revenue 2019: 2.51 billion USD
Revenue 2020: 3.09 billion USD
Revenue 2021: 3.99 billion USD
Revenue 2022: 4.82 billion USD
2023 Revenue Forecast: up to 4.87 billion USD (Note that the reporting segments effective July 1, 2022, began for Q1/2023)
A global leader that enables partners in the pharmaceutical, biotechnology, and consumer health sectors to optimize the development, launch, and delivery of better patient treatments across multiple modalities.
A 2,800-square-meter expansion was recently completed in China’s Waigaoqiao Free Trade Zone (FTZ).
Through its flexible manufacturing platforms at over 50 locations worldwide, the company delivers approximately 80 billion doses of nearly 8,000 products annually.
What do you think of $XAIR ?
P.S. Looking for followers 😊
